Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity.
about
Botulinum toxin for masseter hypertrophyBotulinum toxin for masseter hypertrophyAn evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditionsBotulinum toxin in the treatment of muscle specific Oro-facial pain: a literature reviewBotulinum toxin therapy for osteoarticular pain: an evidence-based review[Clinical management of masticatory muscle pain: an update of the recommendations].Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.Improvement of chronic facial pain and facial dyskinesia with the help of botulinum toxin application.S100 and p65 expression are increased in the masseter muscle after botulinum toxin-A injection.Use of botulinum toxin in musculoskeletal pain.Botulinum toxin treatment of secondary headaches and cranial neuralgias: a review of evidence.Botulinum toxin and the treatment of headache: a clinical review.Botulinum toxin treatment of myofascial pain: a critical review of the literature.The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions - An evidence based review.Botulinum toxin, lidocaine, and dry-needling injections in patients with myofascial pain and headaches.Pharmacological treatment of orofacial pain - Health Technology Assessment including a systematic review with network meta-analysis.Application of botulinum toxin in pain management.The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review
P2860
Q24198174-8C140DDE-DF79-4834-9DC9-16F32072B898Q24241416-D17A4F46-FE8F-4820-BC8C-FF0933C7F080Q24609746-2E0DF136-9D2A-46CD-AA89-87D620E65E1EQ27022558-47D01154-254D-4C46-8176-06AFCEF6FF16Q34554147-E26A3934-0D50-4F97-B304-7A0182AA1779Q34733081-E207D53C-EB72-4251-8860-3F39745D9DD8Q34777570-B4D87EA2-9038-470A-92EE-093600CEB488Q36054611-CF0FDE21-7F5D-4C8F-9C60-32290A101BBBQ37211791-183ABE37-C5EC-4114-9D27-16E24E33C9C3Q37671002-AC9F0E49-7149-40E1-B1B3-63F7A758ABEBQ37895314-C17A5596-CAB5-4D24-A40B-6941228E00DFQ37955981-70828FDF-5EE9-4057-A510-FB3BF87F3B5FQ38025031-AF72B3DD-9248-4524-BA36-EC6D7CD19245Q39145962-CED77F2D-791D-4AD6-8708-EFCAE9F868EEQ39307132-C6732D23-5A69-460E-A8FF-CD7A8F9B91AAQ39400343-F68B1F59-A5CB-4660-AC4E-4241DA6BE91EQ41849757-BA61DFAA-4B4B-4D97-98AA-FF642E31EBC1Q42373798-B0A4A700-2956-4683-9B16-483143A44642
P2860
Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Type A botulinum toxin in the ...... ith masticatory hyperactivity.
@en
Type A botulinum toxin in the ...... ith masticatory hyperactivity.
@nl
type
label
Type A botulinum toxin in the ...... ith masticatory hyperactivity.
@en
Type A botulinum toxin in the ...... ith masticatory hyperactivity.
@nl
prefLabel
Type A botulinum toxin in the ...... ith masticatory hyperactivity.
@en
Type A botulinum toxin in the ...... ith masticatory hyperactivity.
@nl
P2093
P1476
Type A botulinum toxin in the ...... ith masticatory hyperactivity.
@en
P2093
Bernd Niederhagen
Jens J von Lindern
Stefaan Bergé
Thorsten Appel
P304
P356
10.1016/S0278-2391(03)00153-8
P407
P577
2003-07-01T00:00:00Z